Securities Claim Over Walmart’s Opioid Sales Tossed For Lack Of False Statements

(April 10, 2024, 12:23 PM EDT) -- WILMINGTON, Del. — A federal judge in Delaware dismissed a putative class complaint brought by an investor against Walmart Inc. and certain of its executives, finding that the investor did not substantiate the claim that Walmart misled investors about the potential impacts of criminal and civil investigations into its sale of opioids conducted by federal officials in Texas....

Attached Documents

Related Sections